top of page

HOME
COMPANY
NEWS
TECHNOLOGY
- R&D
- QUALITY
SERVICES
CONTACT
More

Use tab to navigate through the menu items.

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.

GC Genome Corporation I Representative: KI CHANG SEOK I Business Registration No. 142-81-61687

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info@gcgenome.com I Tel. +82 31-280-9939 I Fax. +82 31-260-9087

©2021 by GC Genome.

bottom of page